Sanofi has agreed to sell a 50% controlling stake in its consumer healthcare business, Opella, to CD&R, an investment firm. Sanofi had first announced that it was in negotiations to…
The Board of Directors at AbbVie has unanimously elected Robert Michael, the company’s current CEO, to assume the additional position of Chairman, effective July 1, 2025. He will succeed Richard…
FDA Oks Sanofi’s Insulin Biosimilar to Novo Nordisk’s NovoLog
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novo Nordisk’s NovoLog (insulin aspart), called NovoRapid outside of the US, for the improvement of…
The latest from CDMOs, CMOs, and suppliers featuring Seqens, Alcami, and Asahi Kasei Bioprocess America. Chemicals/Chemical API Manufacturing * Seqens Names New CEO Biologics Manufacturing * Asahi Kasei Bioprocess America Names New President Formulation…
A roundup of bio/pharmaceutical news from Biogen/Stoke Therapeutics, AstraZeneca/Fibrogen and Boehringer Ingelheim. Partnering News * Biogen, Stoke In $550-M Pact for Rare-Disease Anti-Seizure Drug M&A News * AstraZeneca To Acquire Fibrogen China in…
Novartis To Acquire Anthos Therapeutics in $3.3-Bn Deal
Novartis has agreed to acquire Anthos Therapeutics, a Boston-based clinical-stage bio/pharmaceutical company, in a deal worth up to $3.3 billion ($925 million upfront and $2.15 billion in milestone payments). Anthos…
Bain Capital To Acquire Mitsubishi Tanabe Pharma for $3.3 Bn
Bain Capital has agreed to acquire Mitsubishi Tanabe Pharma Corporation (MTPC), a Osaka, Japan-based bio/pharmaceutical company, and its subsidiaries in a carve-out transaction from MTPC’s parent company, Mitsubishi Chemical Group…
Supplier News: Axplora, Bio X Cell, SK pharmteco & More
The latest from CDMOs, CMOs, and suppliers featuring Axplora, Bio X Cell, SK pharmteco, Roquette and Frontier Scientific. Chemicals/Chemical API Manufacturing * SK pharmteco Completes Expansion of HPAPI Analytical Testing Lab Biologics…
The latest news on mergers and acquisitions featuring Merck KGaA/SpringWorks Therapeutics and Oramed Pharmaceuticals/Hefei Tianhui Biotech. Highlights below. * Merck KGaA Confirms In Talks for Potential Acquisition of Rare-Disease Drug…
A roundup of bio/pharmaceutical partnering news from AbbVie/Xilio Therapeutics, Eli Lilly and Company/AdvanCell and Eli Lilly and Company/OliX. * AbbVie, Xilio Therapeutics In $2.1-Bn Immunotherapy Oncology Drug Pact * Lilly, AdvanCell…
